Plan B will not be sold over the counter

This is not original reporting. All information has been compiled from The Washington Post.

The Food and Drug Administration denied the over-the-counter-sale of Plan B, which is commonly known as the "morning after pill," due to the lack of proof demonstrating that teenagers could use the contraceptive wisely without a doctor's guidance.

The rejection of Plan B over-the-counter is a victory for social conservatives including members of Congress who pushed President Bush on the issue.

It was a loss to reproductive-rights advocates who had fought for Plan B's approval and were bewildered by FDA's decision.

The agency defended its decision in a letter to Barr Laboratories by pointing out that only 29 of the 585 women studied were under the age of 16, and thus did not prove that the medication was safe for girls younger than 16.

The article stated that the FDA would reconsider their decision if future evidence arose proving that Plan B would be safe for girls under the age of 16.

The original article can be found here.